Back
News

GLA gives go-ahead to London Bridge life sciences scheme

Investor and developer CIT has secured a green light for a 20-storey life sciences-led development at Vinegar Yard, which forms a part of SC1, a new life sciences district at London Bridge, SE1.

Initial plans for the scheme were submitted in 2018 but were revised in October 2021 after planning was refused.

The updated project has been designed by architect Kohn Pedersen Fox Associates in collaboration with Guy’s & St Thomas’ NHS Foundation Trust and King’s College London. It will provide a total of 370,000 sq ft of commercial space for NHS clinical uses, offices and life sciences research companies. About 10% of the floor space is expected to be affordable and will include medical start-up incubator space and artists’ studios managed by Southwark Studios.

Start your free trial today

Your trusted daily source of commercial real estate news and analysis. Register now for unlimited digital access throughout April.

Including:

  • Breaking news, interviews and market updates
  • Expert legal commentary, market trends and case law
  • In-depth reports and expert analysis

Up next…